BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
2.350
+0.110 (4.91%)
At close: Apr 24, 2024, 4:00 PM
2.470
+0.120 (5.11%)
After-hours: Apr 24, 2024, 7:54 PM EDT
BioAtla Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for BioAtla stock have an average target of 14.5, with a low estimate of 7.00 and a high estimate of 25. The average target predicts an increase of 517.02% from the current stock price of 2.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioAtla stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +410.64% | Mar 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +197.87% | Mar 27, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +410.64% | Dec 5, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $10 | Strong Buy | Maintains | $17 → $10 | +325.53% | Nov 8, 2023 |
JP Morgan | JP Morgan | Buy Maintains $17 → $14 | Buy | Maintains | $17 → $14 | +495.74% | Sep 25, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.95M
EPS This Year
-1.97
from -2.58
EPS Next Year
-1.80
from -1.97
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 6.0M | 32.4M | 139.2M | 230.9M |
Avg | n/a | 1.9M | 27.7M | 98.8M | 194.9M |
Low | n/a | n/a | 22.9M | 66.7M | 165.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 1,564.7% | 403.2% | 133.7% |
Avg | - | - | 1,319.6% | 257.1% | 97.3% |
Low | - | - | 1,074.1% | 141.2% | 67.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.87 | -1.01 | -1.85 | -0.36 | 0.71 |
Avg | -1.97 | -1.80 | -2.17 | -1.63 | -0.75 |
Low | -2.10 | -2.32 | -2.39 | -2.80 | -2.11 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.